Literature DB >> 159147

Depressed primary in vitro antibody response in rheumatoid arthritis.

P Segond, J F Delfraissy, P Galanaud, C Wallon, P Massias, J Dormont.   

Abstract

We have studied the primary in vitro antibody response toward a hapten in cultures of peripheral blood lymphocytes from twenty-two patients suffering from regular rheumatoid arthritis (RA). These patients were not receiving immunosuppressive drugs or corticosteroids and had not taken Aspirin or non-steroidal anti-inflammatory agents for at least 72 hr. The control groups included thirty-two healthy subjects and twenty-seven control patients. The mean anti-TNP response of the RA patients was significantly lower than that of both control groups. No pre-existing anti-TNP or IgG response could be detected. A search for suppressor cells in co-cultures of RA and normal lymphocytes was negative. On the contrary, the extent of allogeneic enhancement in such co-cultures was comparable to that observed when control lymphocytes were co-cultured. RA serum added to normal lymphocytes cultures showed a dramatic inhibitory effect in only two out of nine cases. A follow-up study has strongly suggested that RA lymphocytes could increase their in vitro antibody response upon treatment.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 159147      PMCID: PMC1537808     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Plaque formation in agar by single antibody-producing cells.

Authors:  N K JERNE; A A NORDIN
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

2.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

3.  Primary in vitro antibody response of human peripheral blood lymphocytes: role of phagocytic mononuclear cells.

Authors:  J F Delfraissy; P Galanaud; J Dormont; C Wallon
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

4.  Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia.

Authors:  T A Waldmann; M Durm; S Broder; M Blackman; R M Blaese; W Strober
Journal:  Lancet       Date:  1974-09-14       Impact factor: 79.321

5.  Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells.

Authors:  D A Horwitz; K Juul-Nielsen
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

6.  [Study of cellular immunity in rheumatoid arthritis].

Authors:  S Suteanu; M Moanga; D T Stefanesco; A Bancou; C T Dragomir; V Pirvu-Blaja; G Rindasu
Journal:  Rev Rhum Mal Osteoartic       Date:  1978-06

7.  Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.

Authors:  D A Horwitz; M A Garrett
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

8.  Generation of human plaque-forming cells in culture: tissue distribution, antigenic and cellular requirements.

Authors:  E W Gelfand
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

9.  Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by circulating lymphocytes from patients with multiple myeloma Role of suppressor cells.

Authors:  S Broder; R Humphrey; M Durm; M Blackman; B Meade; C Goldman; W Strober; T Waldmann
Journal:  N Engl J Med       Date:  1975-10-30       Impact factor: 91.245

10.  Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus.

Authors:  H E Jasin; M Ziff
Journal:  Arthritis Rheum       Date:  1975 May-Jun
View more
  7 in total

1.  Analysis of impaired in vitro immunoglobulin synthesis in rheumatoid arthritis.

Authors:  I Jokinen; K Poikonen; T Möttönen; P Hannonen; M Oka; J Ilonen; H M Surcel; R Karttunen; H Arvilommi
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

2.  Impaired primary in-vitro antibody response in progressive systemic sclerosis patients: rôle of suppressor monocytes.

Authors:  P Segond; D Salliere; P Galanaud; R M Desmottes; P Massias; J N Fiessinger
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

3.  Clinical evaluation of B cell and T-regulator cell function using a protein A haemolytic plaque assay.

Authors:  B M Jones
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

4.  Age-related impairment of the in vitro antibody response in the human.

Authors:  J F Delfraissy; P Galanaud; J Dormont; C Wallon
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

5.  In vitro immunoglobulin synthesis by lymphocytes from patients with rheumatoid arthritis. I. Effect of monocyte depletion and demonstration of an increased proportion of lymphocytes forming rosettes with mouse erythrocytes.

Authors:  C Plater-Zyberk; M F Clarke; K Lam; P A Mumford; G R Room; R N Maini
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

6.  Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.

Authors:  J F Delfraissy; P Segond; P Galanaud; C Wallon; P Massias; J Dormont
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

7.  Synthesis of IgM, IgG and IgA in rheumatoid arthritis.

Authors:  K Poikonen; M Oka; T Möttönen; I Jokinen; H Arvilommi
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.